123 related articles for article (PubMed ID: 6827530)
1. 1,2-Dihydropyrido[3,4-b]pyrazines: structure-activity relationships.
Temple C; Wheeler GP; Elliott RD; Rose JD; Comber RN; Montgomery JA
J Med Chem; 1983 Jan; 26(1):91-5. PubMed ID: 6827530
[TBL] [Abstract][Full Text] [Related]
2. New anticancer agents: synthesis of 1,2-dihydropyrido[3,4-b]pyrazines (1-deaza-7,8-dihydropteridines).
Temple C; Wheeler GP; Elliott RD; Rose JD; Kussner CL; Comber RN; Montgomery JA
J Med Chem; 1982 Sep; 25(9):1045-50. PubMed ID: 7131483
[TBL] [Abstract][Full Text] [Related]
3. Comparison of 1,2-dihydropyrido[3,4-b]pyrazines (1-deaza-7,8-dihydropteridines) with several other inhibitors of mitosis.
Bowdon BJ; Waud WR; Wheeler GP; Hain R; Dansby L; Temple C
Cancer Res; 1987 Mar; 47(6):1621-6. PubMed ID: 3815360
[TBL] [Abstract][Full Text] [Related]
4. Antimitotic agents: ring analogues and derivatives of ethyl [(S)-5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazin-7- yl]carbamate.
Temple C; Rener GA
J Med Chem; 1992 Dec; 35(26):4809-12. PubMed ID: 1479582
[TBL] [Abstract][Full Text] [Related]
5. Potential antimitotic agents. Synthesis of some ethyl benzopyrazin-7-ylcarbamates, ethyl pyrido[3,4-b]pyrazin-7-ylcarbamates, and ethyl pyrido[3,4-e]-as-triazin-7-ylcarbamates.
Temple C; Rener GA
J Med Chem; 1990 Nov; 33(11):3044-50. PubMed ID: 2231603
[TBL] [Abstract][Full Text] [Related]
6. Biological effects and structure-activity relationships of 1,2-dihydropyrido[3,4-b]pyrazines.
Wheeler GP; Bowdon BJ; Temple C; Adamson DJ; Webster J
Cancer Res; 1983 Aug; 43(8):3567-75. PubMed ID: 6861128
[TBL] [Abstract][Full Text] [Related]
7. Antimitotic agents. Alterations at the 2,3-positions of ethyl (5-amino-1,2-dihydropyrido[3,4-b]pyrazin-7-yl)carbamates.
Temple C; Rener GA; Comber RN; Waud WR
J Med Chem; 1991 Nov; 34(11):3176-81. PubMed ID: 1956035
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of potential anticancer agents: imidazo[4,5-c]pyridines and imidazo[4,5-b]pyridines.
Temple C; Rose JD; Comber RN; Rener GA
J Med Chem; 1987 Oct; 30(10):1746-51. PubMed ID: 3656351
[TBL] [Abstract][Full Text] [Related]
9. New anticancer agents: alterations of the carbamate group of ethyl (5-amino-1,2-dihydro-3-phenylpyrido[3,4-b]pyrazin-7-yl)car bamates.
Temple C; Rener GA; Comber RN
J Med Chem; 1989 Oct; 32(10):2363-7. PubMed ID: 2795608
[TBL] [Abstract][Full Text] [Related]
10. Antimitotic agents. Chiral isomers of ethyl [5-amino-1,2-dihydro-3-(4-hydroxyphenyl)-2-methylpyrido[3,4-b]pyrazin-7 -yl]carbamate.
Temple C; Rener GA
J Med Chem; 1992 Mar; 35(6):988-93. PubMed ID: 1552512
[TBL] [Abstract][Full Text] [Related]
11. New anticancer agents: chiral isomers of ethyl 5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazine-7-car bamate .
Temple C; Rener GA
J Med Chem; 1989 Sep; 32(9):2089-92. PubMed ID: 2769680
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of mitosis and anticancer activity against experimental neoplasms by ethyl 5-amino-1,2-dihydro-3-[(N-methylanilino)methyl]-pyrido[3,4-b]pyrazin-7-ylcarbamate (NSC 181928).
Wheeler GP; Bowdon BJ; Werline JA; Adamson DJ; Temple CG
Cancer Res; 1982 Mar; 42(3):791-8. PubMed ID: 7059977
[TBL] [Abstract][Full Text] [Related]
13. Antimitotic agents: structure-activity studies with some pyridine derivatives.
Temple C; Rener GA; Waud WR; Noker PE
J Med Chem; 1992 Oct; 35(20):3686-90. PubMed ID: 1433180
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of 5-methyl-5-deaza nonclassical antifolates as inhibitors of dihydrofolate reductases and as potential antipneumocystis, antitoxoplasma, and antitumor agents.
Gangjee A; Shi J; Queener SF; Barrows LR; Kisliuk RL
J Med Chem; 1993 Oct; 36(22):3437-43. PubMed ID: 8230134
[TBL] [Abstract][Full Text] [Related]
15. 1-Deaza-7,8-dihydropteridines, a new class of mitotic inhibitors with anticancer activity.
Wheeler GP; Bowdon BJ; Werline JA; Temple C
Biochem Pharmacol; 1981 Aug; 30(16):2381-4. PubMed ID: 7295351
[No Abstract] [Full Text] [Related]
16. Relationship between structure and antineoplastic activity of arylsulfonylhydrazones of 2-formylprydine N-oxide.
Agrawal KC; Sartorelli AC
J Med Chem; 1978 Feb; 21(2):218-21. PubMed ID: 621718
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and potent antifolate activity and cytotoxicity of B-ring deaza analogues of the nonpolyglutamatable dihydrofolate reductase inhibitor Nalpha-(4-amino-4-deoxypteroyl)-Ndelta-hemiphthaloyl- L-ornithine (PT523).
Rosowsky A; Wright JE; Vaidya CM; Bader H; Forsch RA; Mota CE; Pardo J; Chen CS; Chen YN
J Med Chem; 1998 Dec; 41(26):5310-9. PubMed ID: 9857098
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and cytotoxic activity of tetrahydropyridylidene-2- and -4-sulfonamides.
Ho LK; Knaus EE; Allen TM; Fathi-Afshar R
Drug Des Deliv; 1989 Jan; 4(1):35-43. PubMed ID: 2775445
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antineoplastic activity of phenyl-substituted benzenesulfonylhydrazones of 2-pyridinecarboxyaldehyde 1-oxide.
Loh W; Cosby LA; Sartorelli AC
J Med Chem; 1980 Jun; 23(6):631-4. PubMed ID: 7392030
[TBL] [Abstract][Full Text] [Related]
20. Antitumor amino-substituted pyrido[3',4':4,5]pyrrolo[2,3-g]isoquinolines and pyrido[4,3-b]carbazole derivatives: synthesis and evaluation of compounds resulting from new side chain and heterocycle modifications.
Rivalle C; Wendling F; Tambourin P; Lhoste JM; Bisagni E; Chermann JC
J Med Chem; 1983 Feb; 26(2):181-5. PubMed ID: 6827534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
